Deep vein thrombosis of the leg. Is there a "high risk" group?
about
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerLow molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the long term treatment of venous thromboembolism in patients with cancerThe cancer stem cell: evidence for its origin as an injured autoreactive T cellAnticoagulants in cancerThe hypercoagulable state of malignancy: pathogenesis and current debateSome diseases characteristic of modern Western civilizationVaricose veins, deep vein thrombosis, and haemorrhoids: epidemiology and suggested aetiologySubcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trialLow-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic reviewFRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancerUrinary tissue factor: a potential marker of disease.Obesity: its relation to anaesthesia.Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty.Prevention of venous thromboembolism in Wales: results of a survey among general surgeons.Venous thromboses in myocardial infarction. Comparison in heparin dosage.Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass.The incidence of post-operative deep vein thrombosis in general surgical patients of hospital universiti sains malaysiaRisk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patientsThe effect of age upon the coagulation systemPlatelet adhesiveness, coagulation, and fibrinolytic activity in obesity.The incidence of postoperative pulmonary perfusion defects.Systematic lower limb phlebography in acute spinal cord injury in 147 patients.Pulmonary embolism. How to 'nail down' the diagnosis.Venous thromboembolism: epidemiology, diagnosis, prevention.Practical application of 125I-fibrinogen leg scanning.Thrombophlebitis and cancer. A review.Heparin prophylaxis for deep vein thrombosis and pulmonary embolism.Thrombosis, phlebitis, and varicose veins.Deep venous thrombosis in acute spinal cord injury: a comparison of 125I fibrinogen leg scanning, impedance plethysmography and venography.Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement.Non-invasive screening for venous thromboembolic disease.Use of very low-calorie diet in preoperative weight loss: efficacy and safety.
P2860
Q24193749-366D4427-04C9-4EC9-8AC4-0F40491A73A1Q24193871-80D0C9E7-37CD-45E7-84E4-0A580BEFF87BQ24194904-A95104F7-62E0-4273-B5AE-5601C89F9F58Q24234155-B5B86620-5C6E-4563-B1E8-3A66D7FD3136Q24235023-1A856B9B-43C8-45D5-B9A2-8EBECA85DA3EQ24235193-82734BDB-04BE-4260-B4A4-8824B100147CQ24236443-C0A3611A-2FEE-448B-A3BA-EA5A6B650654Q24236620-242252C5-EB2E-4410-B56F-F6E5423BDA87Q24242243-7AF0FA87-E7B6-436E-9D7F-9A8E57B9A12EQ24243286-D3CA234E-DC41-4850-9491-B7BDB75E6995Q25256839-CE7CC410-2F24-419E-B329-41F84ACC59F3Q26825228-614D6A14-C3BA-4971-A326-75756EC953E4Q28212265-E1AE0662-52D1-457B-AF3B-74E368CD313EQ28242950-DC87C38D-FCC5-4B37-B482-F0B1C3CFA136Q28249556-63BCAE94-2ABE-4563-A48E-7A54D7AF47DCQ28354097-D6DD614F-2B28-4A03-83B6-B2CBDA9EA3CFQ33380411-1A4300F9-F497-4F04-A9FA-0B9633AB281FQ33508936-1850FBE8-63C1-4D85-994D-D413815FF483Q33682793-A04BD612-08CD-4539-9BDA-C60961ADB762Q34063252-E33E780A-19BA-420D-9092-DCC7A4542EE5Q34782292-C7F37969-994B-48D8-B963-739FCD24386AQ35513368-82AD680D-BD7D-4C92-8D34-0F18F99C3627Q36101998-2BC9E696-674D-4988-B16B-E5359047BF2AQ36124538-EBE558A8-454E-4CBF-BA75-6C2D0E8A4024Q36222802-49B0A34A-B2F8-4147-ABB3-A493D3B27BBAQ36536307-BCEB6050-B42E-42DF-9FCA-9F05BD7935E5Q36585685-02E43109-DF2E-4A1A-94FA-243D5ABEBA85Q36637755-2961A5C6-06D0-4525-8D73-DEDF64C0B847Q36721095-D61EF120-4A61-432E-AA14-3218412602FDQ37245823-91A67088-5E60-4928-AED0-02392CE78797Q37952154-1102B180-ED00-4A5B-8ED1-F88E71F96F93Q39592542-7D9DBFEC-26BB-4799-8A40-9692CA10B7F3Q40313610-CC04AB29-BCB8-49D9-A280-D542D2184F8DQ40670032-EABC9FC5-0145-4D52-8B57-DDC3F99C23AAQ42126307-5A731377-B51E-489F-AA93-74E43B291882Q43186511-0818F5B8-2E45-458D-9882-4CF21ABD312BQ44076767-41013E39-D728-485E-9AA2-37D1CB6AD3A6Q44157567-11C66FCF-887E-4FBC-B12A-192EF4E29082Q44670746-EA924E15-EE9F-403B-9BF8-92F1D3D3ADD9Q47296387-40D31C5E-2942-4F4F-BDCB-47647FE2E647
P2860
Deep vein thrombosis of the leg. Is there a "high risk" group?
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Deep vein thrombosis of the leg. Is there a "high risk" group?
@en
Deep vein thrombosis of the leg. Is there a "high risk" group?
@nl
type
label
Deep vein thrombosis of the leg. Is there a "high risk" group?
@en
Deep vein thrombosis of the leg. Is there a "high risk" group?
@nl
prefLabel
Deep vein thrombosis of the leg. Is there a "high risk" group?
@en
Deep vein thrombosis of the leg. Is there a "high risk" group?
@nl
P2093
P1476
Deep vein thrombosis of the leg. Is there a "high risk" group?
@en
P2093
A N Nicolaides
J T Renney
M B Clarke
V V Kakkar
P304
P356
10.1016/S0002-9610(70)80023-X
P407
P577
1970-10-01T00:00:00Z